#orthobiologic

[healthcare-skyquest]

Orthobiologics Market: Revolutionizing Bone and Tissue Healing

The Orthobiologics market is transforming the field of orthopedic treatments by offering advanced solutions for bone and tissue healing. With the rising number of sports injuries, aging population, and the growing adoption of minimally invasive surgeries, the demand for orthobiologics is increasing significantly. This article outlines the market trends, segmentation, key growth drivers, and top players shaping the orthobiologics industry.

Market Overview

SkyQuest’s Orthobiologics Market report values the market at USD 6.43 billion in 2023 and projects a robust CAGR of 5.5%. The growth of this market is fueled by the increasing prevalence of musculoskeletal disorders, advancements in regenerative medicine, and the rising demand for effective bone and tissue repair therapies.

Request Your Free Sample: - https://www.skyquestt.com/sample-request/orthobiologics-market

Market Segmentation

By Product:

Bone Grafts: Widely used in bone repair surgeries for better healing and structural support.

Viscosupplementation Products: Help in reducing joint pain by enhancing the lubrication in joints.

Stem Cell Therapy Products: Emerging as a promising solution for tissue regeneration and bone healing.

Platelet-Rich Plasma (PRP) Therapy: Used to accelerate healing in injured tendons, ligaments, and joints.

By Application:

Spinal Fusion: One of the most common applications of orthobiologics in complex spinal surgeries.

Fracture Recovery: Orthobiologics aid in the recovery and regeneration of bone tissues after fractures.

Osteoarthritis: Orthobiologics are being explored for pain relief and tissue regeneration in osteoarthritis patients.

Tendon and Ligament Injuries: Growing use of orthobiologics in treating sports injuries and ligament repairs.

By End-User:

Hospitals: Major providers of surgical procedures involving orthobiologics for musculoskeletal conditions.

Specialty Clinics: Offering focused treatments using orthobiologics for orthopedic injuries and surgeries.

Ambulatory Surgical Centers: Provide outpatient surgeries where orthobiologics play a significant role in faster recovery.

Research Institutes: Contributing to innovations and advancements in orthobiologics through extensive research.

Take Action Now: Secure Your Report Today - https://www.skyquestt.com/buy-now/orthobiologics-market

Key Growth Drivers

Rising Prevalence of Orthopedic Conditions: The growing incidence of osteoporosis, arthritis, and other musculoskeletal disorders is driving the need for orthobiologics.

Technological Advancements in Regenerative Medicine: Cutting-edge technologies are enhancing the effectiveness and safety of orthobiologic products.

Minimally Invasive Surgeries: The increasing adoption of minimally invasive techniques is boosting the demand for orthobiologics, which enhance healing and recovery.

Aging Population: The elderly population is more prone to orthopedic conditions, creating a higher demand for effective bone and tissue healing solutions.

Leading Companies in the Market

SkyQuest’s Orthobiologics Market report highlights the following key players:

Zimmer Biomet

Stryker Corporation

Medtronic

DePuy Synthes (Johnson & Johnson)

Orthofix Medical Inc.

Smith & Nephew

RTI Surgical Holdings

Exactech, Inc.

NuVasive, Inc.

SeaSpine Holdings Corporation

Read More at: - https://www.skyquestt.com/report/orthobiologics-market

Challenges and Opportunities

While the orthobiologics market faces challenges like high treatment costs and regulatory hurdles, there are vast opportunities in product innovations and increasing research in stem cell and tissue regeneration therapies.

Future Outlook

The orthobiologics market is expected to witness strong growth in the coming years as the demand for innovative and less invasive treatment options increases. Companies that invest in research and technological advancements will be better positioned to lead the market.

The orthobiologics market is reshaping orthopedic care by providing advanced solutions for bone and tissue repair. Decision-makers should take advantage of the market's growth potential by staying updated on emerging trends and innovations. For a comprehensive analysis, consult SkyQuest’s Orthobiologics Market report for strategic insights.

[aarunresearcher]

United States orthobiologics market size is projected to exhibit a growth rate (CAGR) of 3.50% during 2024-2032. The growing prevalence of orthopedic disorders, such as osteoarthritis, osteoporosis, and spinal disorders, rising development of more effective and targeted therapies, and increasing advancements in 3D printing, biomaterials, and stem cell research represent some of the key factors driving the market.

[orthotv]

🔰 Vidharbha Orthopedic Society Nagpur, Arthroscopy Society Nagpur , Indian Arthrosocpy society & R L Medical Foundation Presents First Time In India

🏆 PATELLO-FEMORAL MASTER CLASS 🏆

📅 DATE: 22nd & 23rd JUNE 2024

📍 VENUE: HOTEL CENTRE POINT, NAGPUR

🔗 CLICK HERE TO REGISTER : https://tinyurl.com/OrthoTV-PFMC-2024

👨‍⚕️ Dr. Jacob Varghese - Kochi

🔆 Topic Day 1: ▪️Lecture: Orthobiologics in Anterior Knee Pain

🔆 Topic Day 2:

▪️Lecture: Patella preserving surgery for PF Arthritis

▪️Lecture: Management of Post TKA Patella Problems

▪️Debate: Patello Femoral Arthritis Joint Preserving surgery works

Organising Team

👨‍⚕️ Dr. Satyajeet Jagtap - Org. Chairman

👨‍⚕️ Dr. Mukesh Laddha - Course Director

👨‍⚕️ Dr. Sachin Tapasvi - Scientific Chairperson

👨‍⚕️ Dr. Nawaid Ahmed - Org. Secretary

👨‍⚕️ Dr. Anshu Shekhar - Org. Secretary

👨‍⚕️ Dr. Sheetal Gupta - Joint Org. Secretary

👨‍⚕️ Dr. Samir Dwidmuthe - Joint Org. Secretary

📺 Media Partner: OrthoTV Global

📲 Join OrthoTV - https://linktr.ee/OrthoTV

[myblogscmi]

Global Orthobiologics Market to Witness High Growth Owing to Increasing Demand for Advanced Orthopedic Treatments

The global Orthobiologics Market is estimated to be valued at US$ 6,515.2 million in 2022 and is expected to exhibit a CAGR of 5.9% over the forecast period of 2022-2030, as highlighted in a new report published by Coherent Market Insights.

A) Market Overview:

The Orthobiologics Market refers to the use of biomaterials and biologic substances in orthopedic treatment and surgery. These products are used to promote bone healing, repair damaged tissues, and stimulate the growth of new tissues. Examples of orthobiologics products include bone grafts, stem cells, growth factors, and tissue scaffolds. These products find application in various orthopedic procedures such as spinal fusion, joint reconstruction, and trauma repair.

B) Market Dynamics:

The growth of the Orthobiologics Market can be attributed to two major drivers. Firstly, the increasing prevalence of orthopedic conditions, such as osteoarthritis, fractures, and spinal disorders, is driving the demand for advanced orthopedic treatments. Additionally, the growing geriatric population, who are more prone to orthopedic disorders, further contributes to the market growth. The advancements in orthobiologics technology and the development of minimally invasive surgical techniques are also fueling market growth.

For example, stem cell therapies are being increasingly used in orthopedic treatments to promote tissue regeneration and healing. These therapies have shown promising results in accelerating the healing process and reducing recovery time for patients.

C) Market key trends:

One key trend in the Orthobiologics Market is the increasing use of 3D printing technology. 3D printing allows for the production of patient-specific implants, prosthetics, and surgical instruments, which improves surgical outcomes and reduces the risk of complications. For example, 3D-printed bone grafts can be customized to fit the patient's anatomy, enhancing the success rate of spinal fusion surgeries.

D) SWOT Analysis:

- Strengths: Advancements in orthobiologics technology and increasing demand for minimally invasive surgical techniques.

- Weaknesses: High cost associated with orthobiologics treatments and limited reimbursement policies.

- Opportunities: Growing geriatric population and increasing healthcare expenditure in emerging economies.

- Threats: Stringent regulatory approvals for orthobiologics products and the presence of alternative treatment options.

E) Key Takeaways:

In terms of market size, the global Orthobiologics Market is expected to witness high growth, exhibiting a CAGR of 5.9% over the forecast period. This growth can be attributed to the increasing demand for advanced orthopedic treatments driven by the rising prevalence of orthopedic conditions. The fastest growing and dominating region in the market is North America, followed by Europe and Asia Pacific. Key players operating in the global Orthobiologics Market include Zimmer Biomet, Bone Biologics Corp., Globus Medical, Stryker, and Medtronic.

In conclusion, the Orthobiologics Market is experiencing significant growth due to the increasing demand for advanced orthopedic treatments driven by a rise in orthopedic conditions and the growing geriatric population. The adoption of 3D printing technology and advancements in orthobiologics technology further contribute to market growth. However, high costs and limited reimbursement policies pose challenges to market expansion. Overall, the future of the Orthobiologics Market looks promising with opportunities in emerging economies and the development of innovative orthobiologics products.

[insightfulblogz]

Orthobiologics Market Demand, Industry News, and Developments Analysis 2032

Orthobiologics represent a cutting-edge approach to musculoskeletal treatment, using biological substances to promote healing, reduce inflammation, and accelerate tissue regeneration. These therapies include platelet-rich plasma (PRP), stem cells, bone grafts, and hyaluronic acid injections, which are commonly used in treating joint, tendon, ligament, and cartilage injuries. Orthobiologics offer a less invasive alternative to surgery, with treatments tailored to harness the body’s natural healing capabilities. Their application spans across sports medicine, orthopedic surgery, and chronic musculoskeletal conditions, making them a growing field within regenerative medicine.

The Orthobiologics Market was valued USD 7.15 billion in 2023 anticipated to grow USD 11.59 billion by 2032 with compound annual growth rate of 5.55% over the forecast period 2024-2032.

Future Scope

The future of orthobiologics lies in the continued development of advanced regenerative therapies, including gene editing and cell-based therapies. Research into mesenchymal stem cells (MSCs) is particularly promising, with the potential to treat more complex musculoskeletal injuries by regenerating damaged tissues at a cellular level. Personalized orthobiologic treatments, driven by patient-specific data and genetic profiling, are expected to become more prevalent, ensuring that therapies are tailored to individual needs for optimal outcomes. Innovations in bioengineering are also anticipated to enhance the effectiveness of tissue grafts and implants, further pushing the boundaries of regenerative medicine.

Trends

A major trend in orthobiologics is the shift towards minimally invasive treatments, allowing patients to avoid surgical interventions and experience shorter recovery times. The increasing popularity of PRP and stem cell therapies in sports medicine is also notable, with many athletes opting for these treatments to speed up recovery from injuries. Another trend is the combination of orthobiologics with traditional orthopedic procedures, such as using PRP injections alongside joint replacement surgeries to enhance healing. Technological advancements, such as 3D printing, are being explored to create customized scaffolds for tissue regeneration, further expanding the scope of orthobiologics.

Applications

Orthobiologics are applied in a wide range of musculoskeletal treatments, including joint degeneration, tendon and ligament injuries, and bone fractures. PRP therapy is commonly used for conditions like osteoarthritis and tendinitis, where it promotes healing by concentrating growth factors at the injury site. Stem cell therapy is increasingly utilized for regenerating cartilage and treating spinal injuries. Orthobiologics are also widely used in surgical settings, where bone grafts and bioactive materials aid in the healing process after procedures such as spinal fusions and joint replacements. These treatments are favored for their ability to reduce inflammation, promote tissue repair, and enhance recovery.

Get a Free Sample Guide: https://www.snsinsider.com/sample-request/2855 

Key Points

Orthobiologics use biological substances like PRP and stem cells to promote tissue regeneration and healing.

They offer minimally invasive alternatives to surgery, reducing recovery times for patients.

Advances in regenerative medicine, gene editing, and bioengineering are shaping the future of orthobiologics.

Applications include treating joint degeneration, tendon injuries, and enhancing recovery post-surgery.

Conclusion

Orthobiologics are revolutionizing the treatment of musculoskeletal conditions, offering patients new pathways to recovery that harness the body's natural healing mechanisms. With their ability to reduce inflammation, accelerate healing, and provide a less invasive alternative to surgery, orthobiologics are transforming the field of regenerative medicine. As research into stem cells and advanced tissue engineering continues to evolve, orthobiologics are expected to play an even more significant role in orthopedic care, providing personalized and effective solutions for patients seeking long-term relief from chronic injuries and conditions.

[rahulp3]

Orthobiologics Market Trends 2023 Size, Share, Key Drivers, New Innovation, Growth Outlook, Future Scope, and Demand Forecast by 2033

During the forecast period, it is anticipated that the orthobiologics market will grow at a CAGR of 3.0%. The market is expected to reach a value of US$ 8.1 billion by 2033, up from its current share of US$ 6.0 billion in 2023.

The research report titled “Orthobiologics Market: Global Industry Analysis (2012-2016) and Opportunity Assessment (2017-2027)” covers annual sales revenue generated by various market segments during the period of assessment 2017-2027. Furthermore, developments taking place in the market, various trends impacting the performance of the market and other drivers fuelling revenue growth of the global orthobiologics market are enumerated in this elaborate research study. Certain challenges that are pulling market growth southward are also assessed in this report. The report presents a high-level overview of the global orthobiologics market to the reader and extends support in planning future moves by portraying an accurate forecast model of the global orthobiologics market.

To get in-depth insights, ask for a sample report at https://www.futuremarketinsights.com/reports/sample/rep-gb-786

Global Orthobiologics Market: Key Forecast Highlights

The global orthobiologics market research report features the current market scenario as well as the future growth prospects. According to this study, the global orthobiologics market is projected to grow at a CAGR of 3.5% throughout the period of assessment 2017-2027. In 2017, the global orthobiologics market was valued at US$ 4.8 Bn and it is estimated to reach a valuation of more than US$ 6500 Mn by the end of the assessment year (2027).

Global Orthobiologics Market: Highlights on Different Segments

The global market for orthobiologics is segmented by product type, by end user and by region.

By region, North America is expected to be a highly lucrative market for orthobiologics. Several advancements in healthcare along with rising expenditure on research and development in this region are key parameters pushing the growth of the market upward. The orthobiologics market in North America is expected to reach a value over US$ 3 Bn by the end of the forecast period. The orthobiologics market in Asia Pacific excluding Japan (APEJ) is projected to rise at a higher CAGR of 4.4% during the period of forecast.

By end user, the hospitals and ambulatory surgical centres segments are expected to grow at the same pace during the forecast period. However, with respect to revenue, hospitals are a more lucrative option for orthobiologics manufacturers as they have reflected higher demand over the last few years. Orthopaedic clinics are also expected to witness significant growth and register a CAGR of 3.6% during the period of assessment.

By product type, the bone graft stimulators segment is the largest and is estimated to reach a market valuation of more than US$ 3 Bn by the end of 2027. Viscosupplements segment is the second largest and a highly lucrative segment expected to witness a higher pace of growth during the forecast period.

Global Orthobiologics Market: Growth Influencing Factors

Factors such as rising incidence of orthopaedic disorders leading to fractures, increasing incidence of sports injuries, rising adoption of orthobiologics material, rising demand for out-patient surgical procedures, increasing demand for orthopaedic surgeries owing to medical tourism and rising technological developments to enhance surgery time and efficiency are supporting the growth of the global orthobiologics market. But the market is not void of challenges. High cost of orthopaedic surgery, increasing competition causing price fluctuations, lack of awareness, uncertainty about efficacy, availability of alternative therapies and issues related to devices are posing restraints to the growth of the global orthobiologics market.

Global Orthobiologics Market: Competitive Assessment

The research report on the global orthobiologics market delivers a complete package of market intelligence by covering the analysis on participants in the market. Major companies profiled in this research report include Medtronic plc., NuVasive, Inc., Stryker Corporation, Zimmer Biomet Holdings, Orthofix International N.V., Anika Therapeutics, Inc., DePuy Synthes (Johnson & Johnson), Bioventus, Arthrex, Inc., SeaSpine Holdings Corporation, Sanofi-Aventis (Sanofi SA), Djo Global, Inc., Seikagaku Corporation, RTI Surgical, Inc., Heraeus Holding GmbH, Fidia Pharma USA Inc., TRB Chemedica International SA, Allosource, Musculoskeletal Transplant Foundation, Inc., and Ito Co., Ltd.

Last few days to get reports Don’t be delay, Sale is Today offer expires soon!

Important Key phrases:-

Market Forecast.

Company Share Analysis.

Competition Intelligence.

DROT Analysis.

Market Dynamics and Challenges.

Strategic Growth Initiatives

Market segmentation

The global orthobiologics market is segmented in detail so as to cover every aspect of the market and present a complete market intelligence in front of the reader.

By Product Type

Bone Growth Stimulators (BGS)

Non-Invasive Electrical BGS

Invasive Electrical BGS

Ultrasound BGS

Viscosupplements

Single Injection Viscosupplements

Three Injection Viscosupplements

Five Injection Viscosupplements

Bone Graft Substitute

Allografts

Synthetics

Xenografts

Bone Morphogenetic Protein

By End User

Hospitals

Ambulatory Surgical Centres

Orthopaedics Clinics

[trendtrackershq]

𝑺𝒕𝒓𝒂𝒕𝒆𝒈𝒊𝒄 𝑨𝒏𝒂𝒍𝒚𝒔𝒊𝒔 𝒐𝒇 𝒕𝒉𝒆 𝑶𝒓𝒕𝒉𝒐𝒃𝒊𝒐𝒍𝒐𝒈𝒊𝒄𝒔 𝑴𝒂𝒓𝒌𝒆𝒕 

𝑫𝒐𝒘𝒏𝒍𝒐𝒂𝒅 𝑭𝑹𝑬𝑬 𝑺𝒂𝒎𝒑𝒍𝒆: https://www.nextmsc.com/orthobiologics-market/request-sample

The 𝑶𝒓𝒕𝒉𝒐𝒃𝒊𝒐𝒍𝒐𝒈𝒊𝒄𝒔 𝑴𝒂𝒓𝒌𝒆𝒕 is experiencing remarkable growth, driven by advancements in regenerative medicine and an increasing demand for innovative treatments. As we delve into 2024, several key trends are shaping this dynamic field:

𝑻𝒆𝒄𝒉𝒏𝒐𝒍𝒐𝒈𝒊𝒄𝒂𝒍 𝑰𝒏𝒏𝒐𝒗𝒂𝒕𝒊𝒐𝒏𝒔: Breakthroughs in stem cell therapy, gene editing, and tissue engineering are pushing the boundaries of what orthobiologics can achieve. These innovations are not only enhancing treatment efficacy but also expanding the range of conditions that can be addressed.

𝑹𝒊𝒔𝒊𝒏𝒈 𝑫𝒆𝒎𝒂𝒏𝒅 𝒇𝒐𝒓 𝑴𝒊𝒏𝒊𝒎𝒂𝒍𝒍𝒚 𝑰𝒏𝒗𝒂𝒔𝒊𝒗𝒆 𝑷𝒓𝒐𝒄𝒆𝒅𝒖𝒓𝒆𝒔: Patients and healthcare providers alike are increasingly favoring less invasive options that offer quicker recovery times and reduced surgical risks. Orthobiologics is at the forefront of this shift, offering promising alternatives to traditional surgical interventions.

𝑬𝒙𝒑𝒂𝒏𝒅𝒊𝒏𝒈 𝑨𝒑𝒑𝒍𝒊𝒄𝒂𝒕𝒊𝒐𝒏𝒔: From orthopedic injuries to degenerative diseases, orthobiologics is proving to be a versatile solution with applications across a broad spectrum of conditions. The focus is on improving outcomes and enhancing the quality of life for patients.

𝑰𝒏𝒗𝒆𝒔𝒕𝒎𝒆𝒏𝒕 𝒂𝒏𝒅 𝑴𝒂𝒓𝒌𝒆𝒕 𝑬𝒙𝒑𝒂𝒏𝒔𝒊𝒐𝒏: The market is seeing significant investment from both public and private sectors, fueling research and development. This financial backing is essential for accelerating innovation and bringing new therapies to market.

𝑲𝒆𝒚 𝑷𝒍𝒂𝒚𝒆𝒓𝒔:

Stryker Corporation,

Zimmer Biomet Holdings, Inc.

Wright Medical Group, Inc.

Integra LifeSciences Holdings Corporation

Arthrex, Inc. (Arthrex),

Johnson and Johnson (J&J)

Exactec Inc.

Medline Industries, Inc.

Globus Medical, Inc.

NuVasive Inc.

𝑨𝒄𝒄𝒆𝒔𝒔 𝑭𝒖𝒍𝒍 𝑹𝒆𝒑𝒐𝒓𝒕: https://www.nextmsc.com/report/orthobiologics-market

As we continue to monitor the evolution of the Orthobiologics market, it’s clear that the future holds exciting opportunities for advancements in patient care and treatment options. Stay tuned for more updates and insights!

[orthotv]

🗣️We are happy to announce that registrations for Pre & Post Conference Workshops of WIROC 2023 is now open !

🔺Limited seats are available. Book your seat now! ⏭️Register Now at https://wiroc.in/registrations.html

🔰 WIROC 2023 The Classique

58th Annual Conference of Bombay Orthopaedic Society

🎟️ Theme : Brevis, Longus, Magnus

🏟️ Venue : Westin, Powai Lake, Mumbai

🗓️ Date : 28th to 30th December 2023

🔆 THE ETERNAL PURSUIT OF ACADEMIC Excellence

🔸ANNOUNCING PRE & POST CONFERENCE WORKSHOPS

🔸PRE-CONFERENCE WORKSHOPS WEDNESDAY, DECEMBER 27, 2023

🔸Primary Trauma Course (in collaboration with Primary Trauma Care Foundation, UK)

🔸Meniscal Repair Workshop (Cadaveric)

🔸UKR Workshop

🔸Basic Orthoskills Workshop

🔸HTO Workshop

🔸Robotic Technology Workshop

🔸Hip Exposures, Hip Preservation & Osteotomies(Cadaveric)

🔹POST-CONFERENCE WORKSHOPS SUNDAY, DECEMBER 31, 2023

🔹ACL Reconstruction (Cadaveric)

🔹Shoulder Replacement (Cadaveric) Pelvi-Acetabular (Cadaveric)

🔹Hand Surgery (Cadaveric)

🔹Basic Arthroplasty (Cadaveric)

🔹Advanced Spine (Cadaveric)

🔹Acetabular Reconstruction THR

🔹Introduction to Orthobiologics (Cadaveric)

🔹HTO with Root and ACL Reconstruction with Synthetic grafts (Cadaveric)

🔺 SECURE YOUR SPOT BY REGISTERING TODAY. DON'T MISS OUT‼️

👨‍⚕️ Dr. Sanjay Dhar Organising Chairman

👨‍⚕️ Dr. Pradip Nemade Organising Secretary

👨‍⚕️ Dr. Sandeep Biraris Organising Secretary

Click here to Register - https://wiroc.in/registrations.html

for more details visit - www.wiroc.in

[navalvessels]

GlobalData’s “North America Orthobiologic Procedures Outlook to 2030” is a comprehensive databook report, covering key procedures data on the North America Orthobiologic Procedures. 

[meditech-insights]

Global Orthobiologics Market valued at $5.4 billion in 2021 and is anticipated to grow at a CAGR of 7% by 2026

Orthobiologics uses biomaterials and cell-based therapies to heal musculoskeletal injuries quickly and support tissue healing and restoration through their regenerative potential. These products are derived from components that are naturally present in the body and interact dynamically with the musculoskeletal system to facilitate the healing of bone, cartilage, ligament, and diseased or injured meniscus & tendons.

The Global Orthobiologics Market valued at $5.4 billion (2021) is set to witness a growth rate of 7% in the next 5 years. Increasing geriatric and obese populations globally, an increase in the number of people suffering arthritis and other spine-related disorders, an increase in patient preference for minimally invasive procedures, and mechanical advancements in biomaterials are some of the main reasons propelling the global orthobiologics market.

Technological advancements in Orthobiologics Market to fuel its Global Market demand

The development of effective products with enhanced patient healing capacities and expanded applications, among other things, has been made possible by continuous advancements in orthobiologics. As a result, key companies are constantly focusing on investing in research activities for the development of new products and increasing their geographic reach to strengthen their positions in the orthobiologics market. Such advances tend to provide manufacturers a competitive edge.

Below is a list of a few technological developments:

In June 2022, Istos Biologics launched the Influx Fibrant line of 100% cortical allograft products featuring a patented technology from TheraCell and designed to advance patient healing

In March 2022, SeaSpine launched new orthobiologic products- NorthStar cervical facet fusion and Flash navigation lumbar facet fusion, with an aim to streamline reproducible procedural workflow while maximizing the area for fusion

In September 2020, Cerapedics received approval for its i-FACTOR+ Matrix bone graft from Health Canada. This next-generation bone graft is based on P15 osteogenic cell-binding peptide that supports bone growth through cell attraction, attachment, and activation

Explore Premium Report on Orthobiologics Market @ https://meditechinsights.com/orthobiologics-market/

Key Growth Strategies Adopted by Leading Market Players in Orthobiologics Market

Leading Market players operating in the orthobiologics market have accepted acquisition and partnership as key growth strategy to increase their product offerings, improve their geographic presence & distribution capabilities, and to co-develop advanced products.

Some of these developments are listed below -

In August 2022, Orthofix Medical Inc. entered in a strategic partnership with CGBio, a synthetic bone grafts developer, to co-develop and commercialize Novosis recombinant human bone morphogenetic protein-2 (rhBMP-2) bone growth materials and other tissue regenerative solutions for the Canadian and US markets

In July 2021, Celularity Inc. and Arthrex, Inc. entered into a supply and distribution agreement for the distribution and commercialization of multiple products including placental-derived biomaterial products from Celularity for orthopaedics and sport medicine in the US

In March 2021, SeaSpine Holdings Corporation entered in an agreement to acquire 7D Surgical, Inc., a Canada-based medical device company. This acquisition was aimed at combining spinal implant and orthobiologics portfolios to advance spine surgery

Irrespective of the challenges such as unfavorable reimbursement scenario and pricing pressure on market players, the global orthobiologics market is expanding and is anticipated to gain further momentum in the coming years due to a strong emphasis on spinal fusion segment, focus on demineralized bone putties with excipients, growing usage of viscosupplements, and innovations addressing the entire procedure, among others.

For instance, during the forecast period, advances in hyaluronic acid-based therapies, rising prevalence of lifestyle-induced disorders, high efficacy in delaying total knee replacement procedures, and growing preference for non-surgical treatments for osteoarthritis are expected to drive the viscosupplements segment. Furthermore, conventional techniques such as autograft and allograft are difficult to manage, painful for the patient, have fairly contrasting outcomes, and may require repeat surgeries. Hence, an easier-to-use solution is likely to be accepted by doctors and healthcare providers which has greater success rate from a medical and financial standpoint, providing opportunity for market players in this space.

Competitive Landscape Analysis of Orthobiologics Market

The orthobiologics market is marked by the presence of key players such as Medtronic Plc (Ireland); Zimmer Biomet Holdings, Inc. (US); Arthrex, Inc. (US); Bioventus (US); DePuy Synthes (Johnson & Johnson Services, Inc.) (US); Stryker Corporation (US); MTF Biologics (US); and others.

For More Detailed Insights, Contact Us @ https://meditechinsights.com/contact-us/

About Medi-Tech Insights

Medi-Tech Insights is a healthcare-focused business research & insights firm. Our clients include Fortune 500 companies, blue-chip investors & hyper-growth start-ups. We have completed 100+ projects in Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma Services.

Contact:

Ruta Halde

Associate, Medi-Tech Insights

+32 498 86 80 79

info@meditechinsights.com